濮阳东方医院看妇科可靠吗濮阳东方评价好么,濮阳东方医院男科治疗阳痿收费透明,濮阳东方妇科收费透明,濮阳东方看男科专业,濮阳东方医院看妇科病技术比较专业,濮阳东方医院男科价格便宜,濮阳东方看妇科口碑好不好

The subject of the hit podcast “Serial” could be days away from hearing whether he’ll receive a new trial.On Saturday, Adnan Syed's defense attorney Justin Brown tweeted that he's expecting a ruling from the Maryland Court of Special Appeals in the coming week.I expect a ruling from the appeals court this coming week. #FreeAdnan https://t.co/0eQmLaaxFn— Justin Brown (@CJBrownLaw) February 25, 2018 408

The US Office of Special Counsel announced Tuesday that White House aide Kellyanne Conway violated the Hatch Act on two occasions by "advocating for and against candidates" in last year's Alabama Senate special election.In a new report, the OSC special counsel, Henry Kerner, pointed to Conway's TV interviews conducted in her "official capacity" in November and December of last year. The agency said Conway "impermissibly mixed official government business with political views about candidates in the Alabama special election."One of the two interviews was on CNN's "New Day," and the second was on Fox News' "Fox & Friends."In a letter to President Donald Trump, Kerner said he is referring her violations for the President's "consideration of appropriate disciplinary action."The White House did not immediately respond to a request for comment.During the "Fox & Friends" interview November 20, Conway was introduced by the show's hosts as a "counselor to President Trump" and spoke from White House grounds. She said about Democratic Senate candidate Doug Jones: "Folks, don't be fooled. He'll be a vote against tax cuts. He's weak on crime, weak on borders. He's strong on raising your taxes. He's terrible for property owners."During the "New Day" interview December 6, Conway -- again speaking from White House grounds and introduced by CNN anchor Chris Cuomo as "counselor to President Trump" -- said among other things that Jones will be a reliable vote "for tax hikes," "against border security," "against national security," "against the Second Amendment" and "against life," according to the OSC report.Conway went on to tell Cuomo that Jones is "out of step for Alabama voters, according to the President," and that Trump "doesn't want a liberal Democrat representing Alabama in the United States Senate."The Office of Special Counsel is unrelated to the investigation by special counsel Robert Mueller.  1940

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.Alongside the tablets, the agency also approved a diagnostic to detect the mutation."Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.Both treatments were granted Priority Review designation.Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review."A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.Both treatments also received?orphan drug?designation, a status granted to drugs for rare diseases or conditions. 2261

The White House declined to comment Friday about a purported remark about Sen. John McCain by a communications staffer."I'm not going to comment on an internal staff meeting," press secretary Sarah Sanders said of Kelly Sadler's remark that McCain, who is being treated for brain cancer, is "dying."Sanders confirmed Sadler still works at the White House.On Thursday, Sadler, a special assistant who handles surrogate communications, told other staffers that McCain's opposition to President Donald Trump's CIA director nominee, Gina Haspel, does not matter because "he's dying anyway," a White House official told CNN. 627

The U.S. Food and Drug Administration updated its guidance on face coverings on Tuesday, adding information about wearing expired surgical masks.According to the FDA, face and surgical masks may still offer protection even if they've passed their designated shelf life or expiration date."If there is no date available on the face mask label or packaging, facilities should contact the manufacturer. The user should inspect all masks before use and, if there are concerns such as degraded materials (such as elastic) or visible tears," the agency recommends that you should discard the product.However, when it comes to re-using surgical disposal masks, the CDC recommends discarding them after one use.You can clean reusable masks, the CDC says, and recommends washing them after each use. For N95s, which the CDC considers a one-time-use product, but can be re-worn if cleaned with an approved decontamination method. 927